Skip to content

Bone performance of ultraviolet light activated dental implants used for overdentures in patient with moderately controlled diabetes

Comparative evaluation of implant stability quotient and marginal bone loss in conventional and Ultraviolet light photofunctionalized dental implant retained mandibular overdenture in patients with moderately controlled Diabetes Mellitus a randomized controlled clinical study - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/069739
Enrollment
13
Registered
2024-07-01
Start date
Unknown
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K081- Complete loss of teeth

Interventions

Intervention1: photofunctionalization of dental implant: it is the modification for surface treatment for implant in which the implant will be placed in customized photofunctionalization unit for 15 m

Sponsors

Dr Harshal Jain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a Subjects 18 years and above b Completely edentulous upper and lower arches c Edentulous ridge classification as per American College of Prosthodontists (ACP) type III & type lV d Able to provide consent e Patients with moderately controlled type 2 diabetes mellitus f HbA1C value 6.9-8.0 g Patients whose consent for surgical placement of implants is obtained from physician treating them for diabetes

Exclusion criteria

Exclusion criteria: a Patients with systemic diseases or metabolic disorders other than diabetes if any which may impact study b Patients is currently a smoker or quit smoking less than 1 year c Pregnant and lactating women d Patients in whom bone grafting is indicated along with the placement of implants e Patients in whom immediate implants are placed f Patients who have received or are on chemotherapy or radiotherapy or drugs that interfere with implant integration g Patients having any surgical or congenital mandibular defects

Design outcomes

Primary

MeasureTime frame
implant stability quotient and marginal bone loss Timepoint: implant stability quotient and marginal bone loss at baseline 2 months 3 months 6 months and 12 months

Secondary

MeasureTime frame
nilTimepoint: nil

Countries

India

Contacts

Public ContactDr Harshal Shailesh Jain

K M Shah Dental College and Hospital

rajeshsethu77academics@gmail.com9725038434

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Sep 19, 2026